Literature DB >> 23090516

Awareness of endometrial cancer risk and compliance with screening in hereditary nonpolyposis colorectal cancer.

Zohreh Ketabi1, Berit J Mosgaard, Anne-Marie Gerdes, Steen Ladelund, Inge T Bernstein.   

Abstract

OBJECTIVE: Women with hereditary nonpolyposis colorectal cancer (HNPCC) have a 40-60% lifetime risk for endometrial cancer. Guidelines in Denmark recommend gynecologic screening for female members of families with HNPCC. We estimated the knowledge of endometrial cancer risk and identified possible predictors of compliance with the screening among women from families with HNPCC.
METHODS: A questionnaire exploring the knowledge of endometrial cancer risk and compliance with screening was sent to 707 women from families with HNPCC who had been recommended endometrial cancer surveillance. The response rate after one reminder was 86% (606 of 707). Data were analyzed by simple and multivariable logistic regression models.
RESULTS: Four hundred seventy-one women were included in the final analyses; 65% reported being aware of the increased risk of endometrial cancer. The awareness was significantly greater among women with high educational level (81%; P<.001), women who had received genetic counseling (75%; P<.001), women with family history of gynecologic cancer (76%; P<.001), and those with high perceived endometrial cancer risk (77%; P<.001). Overall, 67% had participated in gynecologic screening. No significant differences were found in compliance regarding women's educational level or their family risk classification. Analyses of data in a multivariable logistic regression model showed that knowledge of endometrial cancer risk was the most important predictor for positive compliance with the gynecologic screening (odds ratio 4.86, 95% confidence interval 3.05-7.74).
CONCLUSION: Women's awareness of endometrial cancer risk is the most important predictor of their compliance with gynecologic screening in families with HNPCC. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2012        PMID: 23090516     DOI: 10.1097/aog.0b013e31826ba2aa

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.

Authors:  Kathleen F Mittendorf; Sarah Knerr; Tia L Kauffman; Nangel M Lindberg; Katherine P Anderson; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Jamilyn M Zepp; Sapna Syngal; Benjamin S Wilfond; Katrina A B Goddard
Journal:  JCO Precis Oncol       Date:  2021-11-03

Review 2.  The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.

Authors:  Małgorzata Sobstyl; Peet Brecht; Anna Sobstyl; Paulina Mertowska; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 3.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  Development of an integrated support system for hereditary cancer and its impact on gynecologic services.

Authors:  Mina Morii-Kashima; Hiroshi Tsubamoto; Chika Sato; Mariko Ushioda; Naohiro Tomita; Yasuo Miyoshi; Tomoko Hashimoto-Tamaoki; Kazuo Tamura; Hideaki Sawai; Hiroaki Shibahara
Journal:  Int J Clin Oncol       Date:  2013-12-19       Impact factor: 3.402

Review 5.  Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.

Authors:  Kouji Banno; Yuya Nogami; Iori Kisu; Megumi Yanokura; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923

6.  How does genetic risk information for Lynch syndrome translate to risk management behaviours?

Authors:  Emma Steel; Andrew Robbins; Mark Jenkins; Louisa Flander; Clara Gaff; Louise Keogh
Journal:  Hered Cancer Clin Pract       Date:  2017-01-05       Impact factor: 2.857

7.  Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference.

Authors:  Sarah A Bannon; Maureen Mork; Eduardo Vilar; Susan K Peterson; Karen Lu; Patrick M Lynch; Miguel A Rodriguez-Bigas; Yiqian Nancy You
Journal:  Hered Cancer Clin Pract       Date:  2014-02-05       Impact factor: 2.857

Review 8.  The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.

Authors:  Stephanie A Cohen; Anna Leininger
Journal:  Appl Clin Genet       Date:  2014-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.